References

1. Alpert JS. Nitrate therapy in the elderly. The American Journal of Cardiology, 2002; 65: 23J-27J. (Link)
2. American College of Sports Medicine. (2000). ACSM’s Guidelines for Exercise Testing and Prescription (6th ed). Baltimore: Williams & Wilkins. (Unavailable)
3. American Heart Association (2004). Heart and stroke facts. Retrieved on 4/29/04 from http://www.americanheart.org/presenter.jhtml?identifier=4473 (Link)
4. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent progress in hormone research, 2004; 59: 169-205. (Link)
5. Arauz-Pacheco C, Parrott MA, & Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care, 2002; 25: 134-147. (Link)
6. Biaggioni I, & Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiology clinics, 2002; 20: 291-301. (Link)
7. Booth FW, Chakravarthy MV, Gordon SE, & Spangenburg EE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. Journal of Applied Physiology, 2002; 93: 3-30. (Link)
8. Bradley JG, & Davis KA. Orthostatic hypotension. American Family Physician, 2003; 68: 2393-2398. (Link)
9. Brilla LR, Stephens AB, Knutzen K, & Caine D. Effect of strength training on orthostatic hypotension in older adults. Journal of Cardiopulmonary Rehabilitation, 1998; 18: 295-300. (Link)
10. Brown MD, Dengel DR, Hogikyan RV, & Supaino MA. Sympathetic activity and the heterogenous blood pressure response to exercise training in hypertensives. Journal of Applied Physiology, 2002; 92: 1434-1442. (Link)
11. Brownly KA, West SG, Hinderliter AL, & Light KC. Acute aerobic exercise reduces ambulatory blood pressure in borderline hypertensive men and women. American Journal of Hypertension, 1996; 9: 200-206. (Link)
12. Carroll JF, Pollock ML, Graves JE, & Lowenthal DT. Effect of 6 months of exercise training on cardiovascular responses to head-up tilt in the elderly. Clinical Physiology, 1995; 15: 13-25. (Link)
13. Chen HI, Li HT, & Chen CC. Physical condition decreases norepinephrine-induced vasoconstriction in rabbits: possible roles of norepinephrine evoked endothelium derived relaxing factor. Circulation, 1994; 90: 970-975. (Link)
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the joint national committee of prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. Journal of the American Medical Association, 2003; 289: 2560-2572. (Link)
15. Cleeman JI. Executive summary of the third report of the national cholesterol education program expert panel on detection evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association, 2001; 285: 2486-2497. (Link)
16. Coatmellec-Taglioni G, & Ribiere C. Factors that influence the risk of hypertension in obese individuals. Current Opinion in Nephrology and Hypertension, 2003;12: 305-308. (Link)
17. Convertino VA. Effects of exercise and inactivity on intravascular volume and cardiovascular control mechanisms. Acta Astronautica, 1992; 27: 123-129. (Link)
18. Cybulski G, Krzeminski K, Niewiadomski W, & Nazar K. The influence of endurance training on the transient haemodynamic response to orthostatic manoeuvre. Journal of Physiology and Pharmacology, 1999; 50: 275-286. (Link)
19. El-Atat F, Aneja A, Mcfarlane S, & Sowers J. Obesity and hypertension. Endocrinology and Metabolism Clinics of North America, 2003; 32: 823-854. (Link)
20. Eriksson J, Taimela S, Koivisto VA. Exercise and the Metabolic Syndrome. Diabetologia, 1997; 40: 125-135. (Link)
21. Ferrara LA, Guida L, Iannuzzi R, Celentano A, Lionello F. Serum cholesterol affects blood pressure regulation. Journal of Human Hypertension, 2002; 16: 337-343. (Link)
22. Grassi G, Seravalle G, & Colombo M, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation, 1998; 97: 2037-2042. (Link)
23. Green DJ, Cable NT, Fox C, Rankin JM, Taylor RR. Modification of forearm resistance vessels by exercise training in young men. Journal of Applied Physiology, 1994; 77: 1829-1833. (Link)
24. Gomez-Sanchez CE, Gomez-Sanchez EP, & Yamakita N. Endocrine causes of hypertension. Seminars in Nephrology, 1995; 15: 106-115. (Link)
25. Gonzalez-Juanatey JR. Blood pressure control in patients with type 2 diabetes and hypertension. Diabetes, Obesity and Metabolism, 2001; 4: 81-88. (Link)
26. Hartman RP, Kawashima A, & King BF. (2003). Evaluation of renal causes of hypertension. Radiologic Clinics of North America, 2003; 41: 909-929. (Link)
27. Hsueh WA, & Law RE. Cardiovascular risk continuum: Implications of insulin resistance and diabetes. The American Journal of Medicine, 1998; 105: 4S-14S. (Link)
28. Irving RJ, Walker BR, Noon JP, Watt GC, Webb DJ, & Shore AC. Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovascular Research, 2002; 53: 271-276. (Link)
29. Itoh K, Imai K, Masuda T, Abe S, Tanaka M, Koga R, et al. Association between blood pressure and insulin resistance in obese females during weight loss and weight rebound phenomenon. Hypertension Research: Official Journal of the Japanese Society of Hypertension, 2001; 24: 481-487. (Link)
30. Jordon J, & Biaggioni I. Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension. The Journal of Clinical Hypertension, 2002; 4: 139-145. (Link)
31. Kaplan NM. Hypertension and diabetes. Journal of human hypertension, 2002; 16: S56-S60. (Link)
32. Ketelhut RG, Franz IW, & Scholze J. Regular exercise as an effective approach in antihypertensive therapy. Medicine and Science in Exercise and Sport, 2004; 36: 4-8. (Link)
33. Kingwell BA. Large artery stiffness: Implications for exercise capacity and cardiovascular risk. Clinical and Experimental Pharmacology and Physiology, 2002; 29: 214-217. (Link)
34. Konzem SL, Devore VS, & Baurer DW. Controlling hypertension in patients with diabetes. American Family Physician, 2002; 66: 1209-1214. (Link)
35. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine, 2002; 347: 1483-1492. (Link)
36. Lewington S. The importance of cholesterol, blood pressure and smoking for coronary heart disease. European Heart Journal, 2003; 24: 1703-1704. (Link)
37. Loimaala A, Huikuri HV, Koobi T, & Rinne M. Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes, 2003; 52: 1837-1844. (Link)
38. Maas R, & Boger RH. Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atherosclerosis Supplements, 2003; 4: 5-17. (Link)
39. Maeda ST, Miyauchi T, Kakiyama T, Sugawara J, Iemitsu M, Irukayama-Tomobe Y, & et al. Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sciences, 2001; 69: 1005-1016. (Link)
40. Martel GF, Hurlbut DE, Lott ME, Lemmer JT, Ivey FM, Roth SM, et al. Strength training normalizes resting blood pressure in 65- to 73-year old men and women with high normal blood pressure. Journal of the American Geriatrics Society, 1999; 47: 1215-1221. (Link)
41. Mathias CJ. To stand on one’s own legs. Clinical Medicine, 2002; 2: 236-245. (Link)
42. Mathias CJ, & Kimber JR. Postural hypotension: Causes, clinical features, investigation, and management. Annual Review of Medicine, 1999; 50: 317-336. (Link)
43. Montani JP, Antic V, Yang Z, & Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. International Journal of Obesity, 2002; 26: S28-S38. (Link)
44. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet, 2003; 361: 717-725. (Link)
45. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, & Ray CA. Exercise and hypertension. Medicine and Science in Sports and Exercise, 2004; 36: 533-553. (Link)
46. Reynolds HQ, & Deedwania PC. Treating hypertension in patients with diabetes. The Nurse Practitioner, 2002; 27: 11-21. (Link)
47. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension, 1995; 25: 1135-1143. (Link)
48. Serne EH, Ijzerman RG, de Jongh RT, & Stehouwer CDA. Blood pressure and insulin resistance: role for microvascular function? Cardiovascular research, 2002; 55: 418-419. (Link)
49. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, & Jacobs DR. Relation of insulin resistance to blood pressure in childhood. Journal of Hypertension, 2002; 20: 509-517. (Link)
50. Slawson, D. (2006). Effect of caffeine intake on risk of hypertension. American Family Physician, 73(6), 1081-1082 (Link)
51. Spaak J, Sundblad P, & Linnarsson D. Impaired pressor response after spaceflight and bed rest: evidence for cardiovascular dysfunction. European Journal of Applied Physiology, 2001; 85: 49-55. (Link)
52. Tanzilli G, Barilla F, Pannitteri G, Greco C, Comito C, Schiartiti M, et al. Exercise training counteracts the abnormal release of plasma endothelin-1 in normal subjects at risk for hypertension. Italian Heart Journal, 2003; 4: 107-112. (Link)
53. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. European Heart Journal, 2002; 23: 528-535. (Link)
54. Thulasimani S, & Ramaswamy S. Combined effects of systolic blood pressure, serum cholesterol and smoking on coronary heart disease and stroke. European Heart Journal, 2002; 23: 1887-1888. (Link)
55. Van Dokkum, R. P., Henning, R. H., & de Zeeuw, D. Statins: cholesterol, blood pressure and beyond. Journal of Hypertension, 2002; 20: 2351-2353. (Link)
56. Van Haperen R, de Waard M, van Deel E, Mees B, Kutryk M, van Aken T, et al. Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. The Journal of Biological Chemistry, 2002; 277: 48803-48807. (Link)
57. Van Lieshout JJ. Exercise training and orthostatic intolerance: A paradox? The Journal of Physiology, 2003; 551: 401-402. (Link)
58. Verhaeverbeke I, & Mets T. Drug-induced orthostatic hypotension in the elder: Avoiding its onset. Drug Safety, 1997; 17: 105-118. (Link)
59. Whelton SP, Chin A, Xin X, & He J. Effect of aerobic exercise on blood pressure. Annals of Internal Medicine, 2002; 136: 493-503. (Link)
60. Zhang L, Zheng J, Wang S, Zhange Z, & Liu C. Effect of aerobic training on orthostatic tolerance, circulatory response, and heart rate dynamics. Aviation, Space, and Environmental Medicine, 1999; 70: 975-982. (Link)